Peripheral extracellular vesicles in neurodegeneration: pathogenic influencers and therapeutic vehicles
Open accessThe DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Abstract
Neurodegenerative diseases (NDDs) such as Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis epitomize a class of insidious and relentless neurological conditions that are difficult to cure. Conventional therapeutic regimens often fail due to the late onset of symptoms, which occurs well after irreversible neurodegeneration has begun. The integrity of the blood-brain barrier (BBB) further impedes efficacious drug delivery to the central nervous system, presenting a formidable challenge in the pharmacological treatment of NDDs. Recent scientific inquiries have shifted focus toward the peripheral biological systems, investigating their influence on central neuropathology through the lens of extracellular vesicles (EVs). These vesicles, distinguished by their ability to breach the BBB, are emerging as dual operatives in the context of NDDs, both as conveyors of pathogenic entities and as prospective vectors for therapeutic agents. This review critically summarizes the burgeoning evidence on the role of extracerebral EVs, particularly those originating from bone, adipose tissue, and gut microbiota, in modulating brain pathophysiology. It underscores the duplicity potential of peripheral EVs as modulators of disease progression and suggests their potential as novel vehicles for targeted therapeutic delivery, positing a transformative impact on the future landscape of NDD treatment strategies. Search strategy A comprehensive literature search was conducted using PubMed, Web of Science, and Scopus from January 2000 to December 2023. The search combined the following terms using Boolean operators: “neurodegenerative disease” OR “Alzheimer’s disease” OR “Parkinson’s disease” OR “Amyotrophic lateral sclerosis” AND “extracellular vesicles” OR “exosomes” OR “outer membrane vesicles” AND “drug delivery systems” AND “blood-brain barrier”. MeSH terms were employed when searching PubMed to refine the results. Studies were included if they were published in English, involved human subjects, and focused on the peripheral origins of EVs, specifically from bone, adipose tissue, and gut microbiota, and their association with related diseases such as osteoporosis, metabolic syndrome, and gut dysbiosis. Articles were excluded if they did not address the role of EVs in the context of NDDs or did not discuss therapeutic applications. The titles and abstracts of retrieved articles were screened using a dual-review process to ensure relevance and accuracy. The reference lists of selected articles were also examined to identify additional relevant studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“extracellular vesicles derived from adipose mesenchymal stem cells and umbilical cord mesenchymal stem cells can improve a wide range of age-related phenotypes and delay the ageing process in aged mice.440–442”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [442]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Aged bone matrix-derived extracellular vesicles as a messenger for calcification paradox
Wang, Z.-X., Luo, Z.-W., Li, F.-X.-Z., Cao, J., Rao, S.-S., Liu, Y.-W., Wang, Y.-Y., Zhu, G.-Q., Gong, J.-S., Zou, J.-T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29191-x · Cited by 159 · cited 1×
“Beyond their traditional confines, osteocytes reach into systemic physiology through their secretome, influencing distal organ functions [76, 78, 79].”
BackgroundSelf-citationRetractedZhao, Y., Haney, M. J., Gupta, R., Bohnsack, J. P., He, Z., Kabanov, A. V., & Batrakova, E. V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106867 · Cited by 149
RetractedThe biology , function , and biomedical applications of exosomes
Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770
Shedding light on the cell biology of extracellular vesicles
van Niel, G., D'Angelo, G., & Raposo, G. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.125 · Cited by 8,369 · cited 1×
“Their repertoire extends beyond mere waste disposal to orchestrating physiological and pathological processes, facilitated by their capacity to breach the blood-brain barrier (BBB) and to mediate crosstalk between the CNS and peripheral tissues [7, 8, 11–13].”
BackgroundDementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072 · cited 1×
“Despite extensive research, therapeutic strategies targeting these neuropathological features, specifically aimed at the clearance of Aβ or tau, have not yet resulted in significant clinical benefit [19].”
BackgroundScheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Chételat, G., Teunissen, C. E., Cummings, J., & van der Flier, W. M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32205-4 · Cited by 5,465
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930 · cited 3×
“DC-derived EVs, pivotal in the orchestration of immune responses, also partake in antigen presentation, a function that might be exploit-able for disease-modifying strategies in NDDs [137–139].”
BackgroundBloem, B. R., Okun, M. S., & Klein, C. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00218-x · Cited by 3,920
Mathieu, M., Martin-Jaular, L., Lavieu, G., & Théry, C. (2019) · Nature Cell Biology · doi:10.1038/s41556-018-0250-9 · Cited by 3,737 · cited 1×
“These vesicles, encompassing both exosomes (30– 100 nm) derived from endosomal compartments and the more heterogeneous ectosomes (50–1000 nm), encapsulate a microcosm of the cellular interior, carrying nucleic acids, proteins, lipids, and metabolites across biological frontiers [8–10].”
BackgroundExtracellular vesicles: biology and emerging therapeutic opportunities
EL Andaloussi, S., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,571 · cited 1×
“These naturally occurring nanocarriers harbor the intrinsic ability to encapsulate and convey bioactive molecules—proteins, lipids, and nucleic acids—reflec-tive of their cells of origin, thus preserving the potential for therapeutic modulation [127].”
Background
Cited by
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Malaguarnera, M., & Cabrera‐Pastor, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251810068 · Cited by 53
“To improve the targeting efficacy of EVs, they commonly undergo engineering modifications prior to administration, signifying promising research in the EV therapy for CNS disorders [131].”
BackgroundBone-brain interaction: mechanisms and potential intervention strategies of biomaterials
Yu, J., Ji, L., Liu, Y., Wang, X., Wang, J., & Liu, C. (2025) · Bone Research · doi:10.1038/s41413-025-00404-5 · Cited by 34
“205 This feature is harnessed in in fl ammation-targeted technologies that coat nanoparticles with neutrophil membranes.”
The Multifaceted Role of Extracellular Vesicles in Alzheimer's Disease
Conceição, A. R., Marinatto, J., Pinheiro, L. S., Rody, T., & Felice, F. G. D. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70209 · Cited by 16
Bidirectional communication between the gut microbiota and the central nervous system
Liu, Y., Tang, T., Cai, H., & Liu, Z. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00434 · Cited by 17
Metadata
- Authors
- Liu, X., Shen, L., Wan, M., Xie, H., & Wang, Z.
- Affiliations
- Central South University (CN)
- Corresponding author
- Xie, Hui
- Venue
- Journal of Nanobiotechnology
- Published
- 2024-04-12
- Volume
- 22
- Issue
- 1
- Pages
- 170-170
- ISSN
- 1477-3155 (ISSN-L)
- PMC
- PMC11015679
- OpenAlex
- W4394748794
- Cited by
- 33
- References
- 165
- Citations by year
- 2026: 11 · 2025: 18 · 2024: 4
- FWCI
- 1.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Journal of Nanobiotechnology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (82301625; 81801395; 82125023; 82072504; 81871822; U22A20300, 81971029)
- National Key R&D Program of China (2020YFC2008500)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- extracellular vesicles, neurodegenerative diseases, blood-brain barrier, drug delivery, gut microbiota, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, exosomes, outer membrane vesicles, osteoporosis, metabolic syndrome, gut dysbiosis
- MeSH terms
- Extracellular Vesicles, Alzheimer Disease, Humans, Parkinson Disease, Prospective Studies, Exosomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Peripheral extracellular vesicles in neurodegeneration: pathogenic influencers and therapeutic vehicles. https://app.cochat.ai/papers/10.1186/s12951-024-02428-1
- The paper
- Liu, X., Shen, L., Wan, M., Xie, H., & Wang, Z. (2024). Peripheral extracellular vesicles in neurodegeneration: pathogenic influencers and therapeutic vehicles. Journal of Nanobiotechnology. https://doi.org/10.1186/s12951-024-02428-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.